Oku Afiong O, Owoaje Eme T, Ige Olusimbo K, Oyo-Ita Angela
Department of Community Medicine, University of Calabar Teaching Hospital, Calabar, Cross river state, Nigeria.
BMC Infect Dis. 2013 Aug 30;13:401. doi: 10.1186/1471-2334-13-401.
Adherence to Highly active antiretroviral therapy (HAART) is a major predictor of the success of HIV/AIDS treatment. Good adherence to HAART is necessary to achieve the best virologic response, lower the risk of drug resistance and reduce morbidity and mortality. This study therefore aimed to determine the prevalence and determinants of adherence to HAART amongst PLHIV accessing treatment in a tertiary location in Cross River State, Nigeria.
A cross-sectional study was conducted among patients on HAART attending the Presidential Emergency plan for AIDS relief (PEPFAR) clinic of the University of Calabar Teaching Hospital between October-December 2011. A total of 411 PLHIV visiting the study site during the study period were interviewed. PLHIV who met the inclusion criteria were consecutively recruited into the study till the desired sample size was attained. Information was obtained from participants using a semi-structured, pretested, interviewer administered questionnaire. Adherence was measured via patients self report and were termed adherent if they took at least 95% of prescribed medication in the previous week prior to the study. Data were summarized using proportions, and χ2 test was used to explore associations between categorical variables. Predictors of adherence to HAART were determined by binary logistic regression. Level of significance was set at p < 0.05.
The mean age of PLHIV who accessed treatment was 35.7 ± 9.32 years. Females constituted 68.6% of all participants. The self reported adherence rate based on a one week recall prior to the study was 59.9%. The major reasons cited by respondents for skipping doses were operating a busy schedule, simply forgot medications, felt depressed, and travelling out of town. On logistic regression analysis, perceived improved health status [OR 3.11; CI: 1.58-6.11], reduced pill load [OR 1.25; 95% CI: 0.46-2.72] and non-use of herbal remedies [OR 1.83; 95% CI: 1.22-2.72] were the major predictors for adherence to HAART. However, payment for ART services significantly decreased the likelihood of adherence to HAART. [OR 0.46; 95% CI: 0.25-0.87.].
The adherence rate reported in this study was quite low. Appropriate adherence enhancing intervention strategies targeted at reducing pill load and ensuring an uninterrupted access to free services regimen is strongly recommended.
坚持高效抗逆转录病毒疗法(HAART)是艾滋病毒/艾滋病治疗成功的主要预测指标。良好地坚持HAART对于实现最佳病毒学反应、降低耐药风险以及降低发病率和死亡率至关重要。因此,本研究旨在确定在尼日利亚克罗斯河州一个三级医疗机构接受治疗的艾滋病毒感染者中HAART的依从率及其决定因素。
2011年10月至12月期间,在卡拉巴尔大学教学医院总统艾滋病紧急救援计划(PEPFAR)诊所对接受HAART治疗的患者进行了一项横断面研究。在研究期间,共有411名到研究地点就诊的艾滋病毒感染者接受了访谈。符合纳入标准的艾滋病毒感染者被连续纳入研究,直至达到所需样本量。通过使用半结构化、经过预测试、由访谈者管理的问卷从参与者那里获取信息。依从性通过患者自我报告来衡量,如果他们在研究前的前一周服用了至少95%的规定药物,则被称为依从者。数据使用比例进行汇总,并使用χ2检验来探索分类变量之间的关联。通过二元逻辑回归确定HAART依从性的预测因素。显著性水平设定为p < 0.05。
接受治疗的艾滋病毒感染者的平均年龄为35.7±9.32岁。女性占所有参与者的68.6%。根据研究前一周的回忆自我报告的依从率为59.9%。受访者提到的漏服药物的主要原因是日程繁忙、单纯忘记服药、感到沮丧以及出城旅行。在逻辑回归分析中,自我感觉健康状况改善[比值比(OR)3.11;置信区间(CI):1.58 - 6.11]、药片负担减轻[OR 1.25;95% CI:0.46 - 2.72]和不使用草药疗法[OR 1.83;95% CI:1.22 - 2.72]是HAART依从性的主要预测因素。然而,抗逆转录病毒治疗服务的费用显著降低了坚持HAART的可能性。[OR 0.46;95% CI:0.25 - 0.87]。
本研究报告的依从率相当低。强烈建议采取适当的提高依从性的干预策略,以减轻药片负担并确保不间断地获得免费治疗方案。